Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Retained Earnings (2016 - 2025)

HealthLynked (HLYK) has disclosed Retained Earnings for 10 consecutive years, with -$50.5 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 4.93% to -$50.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$50.5 million through Dec 2025, down 4.93% year-over-year, with the annual reading at -$50.5 million for FY2025, 4.93% down from the prior year.
  • Retained Earnings for Q4 2025 was -$50.5 million at HealthLynked, roughly flat from -$50.8 million in the prior quarter.
  • The five-year high for Retained Earnings was -$29.6 million in Q1 2021, with the low at -$50.8 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$40.8 million, with a median of -$40.9 million recorded in 2022.
  • The sharpest move saw Retained Earnings crashed 78.26% in 2021, then decreased 2.47% in 2023.
  • Over 5 years, Retained Earnings stood at -$32.2 million in 2021, then fell by 27.37% to -$41.0 million in 2022, then decreased by 2.47% to -$42.0 million in 2023, then decreased by 14.59% to -$48.2 million in 2024, then dropped by 4.93% to -$50.5 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$50.5 million, -$50.8 million, and -$49.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.